BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191118
DTEND;VALUE=DATE:20191121
DTSTAMP:20260515T032502
CREATED:20180531T073809Z
LAST-MODIFIED:20190605T115541Z
UID:16039-1574035200-1574294399@www.pharmajournalist.com
SUMMARY:Ophthalmic Drugs
DESCRIPTION:SMi Group are pleased to present the 3rd Annual Ophthalmic Drugs Conference and Focus Day\, taking place on the 18th-20th November 2019 in London\, UK. \n \nThe global ophthalmic drug market size is expected to reach a value of $30 billion USD by 2023 with growing focus on alternative delivery approaches to replace intravitreal drug delivery and novel drug development being the key factors driving the market. \nWith this in mind\, this year’s Ophthalmic Drugs conference will explore new discoveries in the treatment of ocular rare disease; innovations in gene therapy; the challenges in drug delivery through a complex barrier; patient comfort and regulatory compliance which make up  core components within the Ophthalmic Drug sphere. \nNEW FOR 2019: \nThe brand-new Focus Day on ‘Novel Drug Delivery Through a Complex Barrier’ will bring academic perspectives on the future for ocular drug delivery and notified bodies will provide a regulatory insight into this emerging field of ophthalmic drug development. \nHow will you benefit? \nWith over 15 expert presentations\, the three-day agenda offers you peer-to-peer networking with Global Product Managers\, Heads of Drug Development\, Senior Directors of Ophthalmology\, Heads of Research and Development and many more! \nNetwork and learn from leading professionals such as: \nCHAIRS FOR 2019: \n\nMitchell de Long\, Vice President\, Chemistry\, Aerie Pharmaceuticals\nNaj Sharif\, Vice President\, Global Ophthalmology\, Santen Inc\, USA\n\nFEATURED SPEAKERS INCLUDE: \n\nParisa Zamiri\, Global Head of Clinical Development in Ophthalmology\, Novartis Pharmaceutical Inc.\nGavin Spencer\, Executive Vice President and Chief Business Officer\, Nicox\nAniz Girach\, Chief Medical Officer\, ProQR Therapeutics\nDaniel Chung\, Global Medical Strategy Lead- Ophthalmology\, Spark Therapeutics\nMichael Ehrlich\, Senior Clinical Program Lead – Retinopathies\, Boehringer Ingelheim\nPeter Morgan-Warren\, Medical Assessor\, MHRA\nWilliam Dallman\, Clinical Development Manager\, Eyenuk\n\nFor more information and to register\, visit: www.ophthalmicdrugs.com/pj \nEarly-Bird Rates \n\nBOOK BY 28TH JUNE AND SAVE £300\nBOOK BY 30TH SEPTEMBER AND SAVE £100\n\nSocial Media Handles \nFollow us on LinkedIn ‘SMi Pharma’\, Twitter @SMiPharm and use #OphthalmicDrugs \nContact Info: \nT: +44 (0) 20 7827 6164\nE: nhoward@smi-online.co.uk
URL:https://www.pharmajournalist.com/event/ophthalmic-drugs-2019/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SMi Group Ltd":MAILTO:nhoward@smi-online.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20191118
DTEND;VALUE=DATE:20191121
DTSTAMP:20260515T032502
CREATED:20180905T081807Z
LAST-MODIFIED:20190717T092148Z
UID:17493-1574035200-1574294399@www.pharmajournalist.com
SUMMARY:3rd Annual Anti-Fibrotic Drug Development Summit (AFDD) 2019
DESCRIPTION:AFDD is back for its third year as the only conference to bring together industry leaders\, clinicians and academic experts focused on finding an effective anti-fibrotic treatment. \n \nOver 3 days packed with compelling case studies\, diverse panels and varied networking opportunities\, you’ll glean insights from industry and academic leaders across fibrotic disease areas. The 2019 agenda will reflect the strides taken by the community over the past year as well as forming the future of anti-fibrotic drug development. \nTo learn more about this event\, and to register online\, visit https://afdd-summit.com/ \nContact:\nPhone – (+1) 617 455 4188\nEmail – info@hansonwade.com
URL:https://www.pharmajournalist.com/event/afdd-summit-2019/
LOCATION:Revere Hotel Boston Common\, 200 Stuart Street\, Boston\, MA\, 02116\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR